PathAI’s Post

Tune in to Episode 2 of ACRO's Good Clinical Podcast, where Stephen Pyke and the FDA's Dr. Tala Fakhouri discuss the massive potential of AI in clinical research. 🎙   Learn more about the FDA's evidentiary standards for AI, the importance of methodological transparency in submissions and how AI stands to streamline the drug development process, helping to bring life-changing medicines to market more efficiently. 💡 Stephen also sheds light on where AI advancements will show up and what it means for patients. 👇 Watch below! Don’t miss this fascinating discussion. Access the full episode here: https://lnkd.in/gdMz_agR #ACRO #GoodClinicalPodcast #ArtificialIntelligence 

Check out the Alldus #AIinAction #podcast to learn more about how Alltrna applies #AI and #machinelearning to unlock #tRNA biology and scale #geneticmedicines for #rarediseases. #StopCodonDisease

🚀 Exciting insights from the latest episode of the BioBreakthroughs podcast! 🌟 Host Jared S. Taylor dives into the complexities of clinical trial feasibility with experts Rohit Nambisan, CEO of Lokavant, and Christine Senn, PhD, SVP at Advarra. During this episode, Rohit and Christine discuss: 🔎 Clinical Trial Feasibility Challenges and the use of AI to tackle the daunting task of identifying patient populations for rare disease trials, emphasizing the need for precise patient density identification and low participant burden. 🏥 Site Perspectives and the importance of thorough feasibility assessments, and how rushed processes and incomplete information can lead to trial delays. 🤖 AI and Technology in Trials and it's transformative potential in predictive modeling and patient identification. Catch the full episode for a deeper dive into how AI and technology are revolutionizing clinical trials! 🎧 https://lnkd.in/dB2qMF9s #ClinicalTrials #AI #Biotech #Pharma #Innovation #HealthcareTech

𝗛𝗼𝘄 𝗰𝗮𝗻 𝗔𝗜 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗲𝗳𝗳𝗼𝗿𝘁𝘀?* Hear Senior Principal Regulatory Scientist Bethany Knorr Chung, PhD, RAC speak to this in a short clip taken from a longer podcast episode about AI and In Vitro Diagnostics. You can listen to the entire conversation with Margot Borgel, Ph.D. on the RQM+ Device Advice podcast (🔗 in comments). *Fern.ai is mentioned in Bethany's answer and we encourage you to give it a look. 👀 #AI #IVD #MedTech

#ICYMI 𝐄𝐢𝐠𝐡𝐭 𝐃𝐫𝐮𝐠𝐬 𝐚 𝐖𝐞𝐞𝐤, 𝐄𝐩𝐢𝐬𝐨𝐝𝐞 10 – 𝐌𝐚𝐜𝐡𝐢𝐧𝐞 𝐥𝐞𝐚𝐫𝐧𝐢𝐧𝐠 𝐚𝐧𝐝 𝐀𝐈 𝐟𝐨𝐫 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥𝐢𝐬𝐞𝐝 𝐭𝐡𝐞𝐫𝐚𝐩𝐲: 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐭𝐡𝐞𝐧 In this episode, we are lucky to be joined by two experts from the field of pharmacokinetic and pharmacodynamic modelling, Michael Neely and Jean-Baptiste Woillard. We hear about: 💡 The differences between traditional population pharmacokinetics and machine learning approaches in predicting drug exposure and optimizing dosing regimens. 💡Some advantages of ML approaches, including in handling nonlinear patterns. 💡The challenge of interpretability of results and dose recommendations from machine learning methods compared to traditional pharmacokinetic methods. 💡Which clinical contexts we will soon see machine learning derived models applied to clinical care. 💡The future of modelling and machine learning in pharmacology, including ethical considerations and the concept of augmented intelligence. 🎧 Tune in on your favorite podcast platform: Apple Podcasts 🔗 https://lnkd.in/gJd94qDh Google Podcasts🔗 https://lnkd.in/d65F7e8J Spotify 🔗 https://lnkd.in/gDixSbXx

#podcast Vin Singh, Founder & CEO of Bullfrog AI, discusses how AI is being used to improve the drug development process through a precision medicine approach that looks at a combination of genetic & non-genetic attributes to predict patient response to drugs. Bullfrog AI aims to reduce the failure rate in late-stage trials by enrolling the right patients in clinical trials. Through their partnership with the Johns Hopkins Lieber Institute for Brain Development, they use AI to analyze a unique dataset of post-mortem brains to discover new drug targets & improve clinical trial design. #BullfrogAI #AI #DrugDevelopment #ClinicalTrials #LieberInstitute #JohnsHopkinsUniversity  Bullfrogai.com https://lnkd.in/g_VVyq8E

Latest episode of Data in Biotech is now live! 🎙️ This week, Ross Katz sat down with Michael Nally, CEO at Generate:Biomedicines - a pioneer in generative biology that is transforming the way medicines are developed. Over this fascinating conversation, Mike shared his thoughts on the AI-driven drug development landscape and how data is set to change the way every drug is made in the future. We covered: → The latest in drug development trends, from how the availability of data accelerates what is possible to breakthroughs in de novo generation that allow proteins to be developed with unprecedented specificity. → Mike's view on the current status of machine learning's role in biotech R&D and how this will evolve. → How Generate innovates at each phase of AI-driven drug development. → And the value of Chroma, an open-source diffusion model from Generate that allows scientists to push the boundaries of protein discovery. Check it out on Apple, Spotify or wherever you get your podcasts. Apple: https://lnkd.in/e8y_hNUJ Spotify: https://lnkd.in/e8-K6KFu #data #biotech #drugdevelopment

#GenAI #Chatbots are revolutionizing healthcare! 🚀 In my latest Spotify podcast, I dive into how #RAG and #LLMs are transforming health sciences. Discover 10 powerful use cases and learn how to build your own chatbot. Listen now and stay ahead of the curve! #Spotify: https://lnkd.in/eSiaPCH9 #healthcare #chatbots #AI #LLM #RAG #podcast #healthtech

🎙️ Exciting New Episode Alert! 🎙️ Join us on the LetsTok Podcast for a deep dive into the future of AI in sales with industry experts Sukumar Rajagopal, CEO of Tiny Magiq and Kumaran Anandan, CTO in the same firm. In this thought-provoking episode, we unravel the challenges and opportunities in selling engineering products, while shedding light on the impact of AI on job displacement and transformative healthcare solutions. Key Takeaways: Learn about the concept of "performance under supply" and its significance in effective solution selling. Discover strategies for qualifying sales leads and focusing on the right customers for maximum impact. Gain valuable insights into cutting-edge innovations and the importance of swiftly providing innovative solutions to stay competitive. Understand the unique challenges and risks in selling to medical and pharmaceutical companies. Explore the transformative impact of AI in healthcare, from ambient health documentation to streamlining hospital processes. Tune in to gain a wealth of knowledge and stay ahead in the ever-evolving landscape of AI! 🚀 Links in the comment section. #AITechnology #SalesStrategies #AIHealthcare #SalesInnovation #LetsTokPodcast

This week, the Alldus podcast hosted Fog Chief Data Officer, Brandon Allgood, Ph.D., for a discussion on his career applying machine learning and large-scale computational methods to improve human health. The conversation highlighted Brandon’s industry leadership and expertise in this important discipline and how we’re combining biology and chemistry with data science advances to revolutionize the discovery and development of transformational medicines.    Our data science efforts are robust and growing at Fog, and we’re building the team to support that growth. We’re currently hiring for the following roles on Brandon’s team:     - Sr. Scientist, Machine Learning   - Principal Data Product Engineer  - Sr. Data Scientist, Cheminformatics    Learn more about these positions here: https://bit.ly/3VSwmAx     #TeamFogPharma #BiotechJobs #machinelearning #artificialintelligence #AI